Smith & Nephew plc (SN) 2009年年度报告「LSE」.pdf

1、2009 Annual ReportEnabling people to live healthier,more active lives.Shanghai is the head office of our China business,where we recently opened a new surgeon training institute,the first of five planned.During 2009,in nearby Suzhou,we completed our new Advanced Wound Management manufacturing facili

2、ty and we have commenced construction of an Orthopedics facility near Beijing.The emerging markets,which include China,are part of Smith&Nephews investing for growth initiative,one of our four strategic pillars for success.INTRODUCTION AND FINANCIAL SUMMARYThe Smith&Nephew Group(the“Group”)is a glob

3、al medical devices business operating in the orthopaedics,endoscopy and advanced wound management markets,with revenue of approximately$3.8 billion in 2009.Smith&Nephew plc is the parent company(the“Company”)of the Group.It is an English public limited companywith its shares listed on the official l

4、ist of the UK Listing Authority and traded on the London Stock Exchange.It isalso traded on the New York Stock Exchange in the form of American Depositary Shares(“ADSs”).This report is the Annual Report of Smith&Nephew plc for the year ended 31 December 2009.It comprises in asingle document,the Annu

5、al Report and Accounts of the company in accordance with UK requirements and theAnnual Report on Form 20-F in accordance with the regulations of the United States Securities and ExchangeCommission(“SEC”).A summary report on the year,the 2009 Summary Annual Review,intended for the investor who does n

6、ot requirethefulldetailoftheAnnualReport,isavailableonSmith&Nephew scorporatewebsiteatwww.smith- along with the electronic version of this Annual Report.The Summary AnnualReview includes a summary remuneration report and summary financial statements.For the convenience of the reader,a Glossary of te